權威金融(00397.HK)擬受讓5000萬港元貸款
格隆匯4月3日丨權威金融(00397.HK)發佈公告,2020年4月3日,受讓人(公司一家間接全資附屬公司)及轉讓人(一名獨立第三方)訂立契據,據此(i)貸款協議;及(ii)按揭內各自所有權益及利益已由轉讓人以現金代價5000萬港元轉讓予受讓人。
該貸款由轉讓人授予借款人(一名獨立第三方),該貸款本金額為5000萬港元,按年利率17釐計息,自2019年12月9日至2020年6月9日止為期6個月。該貸款由按揭作抵押。
轉讓貸款及抵押品實質上已導致受讓人向借款人墊付一筆本金額為5000萬港元的該貸款,該貸款按年利率17釐計息,期限為自2020年4月3日至6月9日,且所有與該貸款有關的到期款項均由按揭作抵押。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.